BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17189721)

  • 1. Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation.
    Bakiri L; Takada Y; Radolf M; Eferl R; Yaniv M; Wagner EF; Matsuo K
    Bone; 2007 Apr; 40(4):867-75. PubMed ID: 17189721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation.
    Matsuo K; Owens JM; Tonko M; Elliott C; Chambers TJ; Wagner EF
    Nat Genet; 2000 Feb; 24(2):184-7. PubMed ID: 10655067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
    J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
    Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
    Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
    Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
    Eriksson M; Taskinen M; Leppä S
    J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells.
    Pang M; Martinez AF; Fernandez I; Balkan W; Troen BR
    Gene; 2007 Nov; 403(1-2):151-8. PubMed ID: 17897792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo anergized CD4+ T cells have defective expression and function of the activating protein-1 transcription factor.
    Sundstedt A; Dohlsten M
    J Immunol; 1998 Dec; 161(11):5930-6. PubMed ID: 9834073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
    Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y
    Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
    Chuĭkin IA; Lianguzova MS; Pospelov VA
    Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
    Ramirez-Carrozzi VR; Kerppola TK
    J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of early response genes in trypsin inhibitor-induced pancreatic growth.
    Guo L; Sans MD; Gurda GT; Lee SH; Ernst SA; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G667-77. PubMed ID: 17095753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AP-1 regulates alpha2beta1 integrin expression by ERK-dependent signals during megakaryocytic differentiation of K562 cells.
    Eriksson M; Arminen L; Karjalainen-Lindsberg ML; Leppä S
    Exp Cell Res; 2005 Mar; 304(1):175-86. PubMed ID: 15707584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AP-1 mediated retinal photoreceptor apoptosis is independent of N-terminal phosphorylation of c-Jun.
    Grimm C; Wenzel A; Behrens A; Hafezi F; Wagner EF; Remé CE
    Cell Death Differ; 2001 Aug; 8(8):859-67. PubMed ID: 11526439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing functions of ATF2 and Fos-like transcription factors in c-Jun-mediated myogenin expression and terminal differentiation of avian myoblasts.
    Daury L; Busson M; Tourkine N; Casas F; Cassar-Malek I; Wrutniak-Cabello C; Castellazzi M; Cabello G
    Oncogene; 2001 Nov; 20(55):7998-8008. PubMed ID: 11753683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase II is an AP-1 target gene in osteoclasts.
    David JP; Rincon M; Neff L; Horne WC; Baron R
    J Cell Physiol; 2001 Jul; 188(1):89-97. PubMed ID: 11382925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
    Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
    Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of c-Jun concentration in neuronal cell death.
    Rössler OG; Steinmüller L; Giehl KM; Thiel G
    J Neurosci Res; 2002 Dec; 70(5):655-64. PubMed ID: 12424733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fra-1 potentiates osteoclastic differentiation in osteoclast-macrophage precursor cell lines.
    Owens JM; Matsuo K; Nicholson GC; Wagner EF; Chambers TJ
    J Cell Physiol; 1999 May; 179(2):170-8. PubMed ID: 10199556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.